Skip to main content
. 2017 Nov 16;113(3):484–493. doi: 10.1111/add.14033

Table 2.

Absolute (F%) and relative (Fi.m.%) mean bioavailability (90% confidence interval) based on area under the curve up to last measurable time‐point.

Reference n 1 mg i.n. 2 mg i.n. 4 mg i.n.
Fi.m.% 0.4 mg i.m. 32 50.8 (45.2, 57.1) 47.1 (41.5, 53.5) 48.3 (43.2, 54.1)
F% 0.4 mg i.v. 32–33 50.2 (44.6, 56.6) 46.8 (41.7, 52.6) 48.1 (43.3, 53.5)

i.n. = intranasal; i.m. = intramuscular.